Outlining a Novel Hydrophilic Nanoparticle mRNA-Based Platform to Deliver Antigen-Specific Immune Therapies in Autoimmune Diseases

12:30 pm - Wednesday 11th November 2026

  • Discussing tissue specific delivery with hydrophilic nanoparticle
  • Reviewing antigen-specific immune tolerance
  • Exploring tunable immune modulation

Speakers:

Chief Executive Officer
BreezeBio